153 related articles for article (PubMed ID: 36125949)
41. Coincidental Onset of Ocular Myasthenia Gravis Following ChAdOx1 n-CoV-19 Vaccine against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2).
Galassi G; Rispoli V; Iori E; Ariatti A; Marchioni A
Isr Med Assoc J; 2022 Jan; 24(1):9-10. PubMed ID: 35077038
[TBL] [Abstract][Full Text] [Related]
42. A Systematic Review of Reported Cases of Immune Thrombocytopenia after COVID-19 Vaccination.
Saluja P; Amisha F; Gautam N; Goraya H
Vaccines (Basel); 2022 Sep; 10(9):. PubMed ID: 36146522
[TBL] [Abstract][Full Text] [Related]
43. Serious neurological adverse events following immunization against SARS-CoV-2: a narrative review of the literature.
Eslait-Olaciregui S; Llinás-Caballero K; Patiño-Manjarrés D; Urbina-Ariza T; Cediel-Becerra JF; Domínguez-Domínguez CA
Ther Adv Drug Saf; 2023; 14():20420986231165674. PubMed ID: 37223456
[TBL] [Abstract][Full Text] [Related]
44. Pathologic Antibodies to Platelet Factor 4 after ChAdOx1 nCoV-19 Vaccination.
Scully M; Singh D; Lown R; Poles A; Solomon T; Levi M; Goldblatt D; Kotoucek P; Thomas W; Lester W
N Engl J Med; 2021 Jun; 384(23):2202-2211. PubMed ID: 33861525
[TBL] [Abstract][Full Text] [Related]
45. COVID-19 vaccine waning and effectiveness and side-effects of boosters: a prospective community study from the ZOE COVID Study.
Menni C; May A; Polidori L; Louca P; Wolf J; Capdevila J; Hu C; Ourselin S; Steves CJ; Valdes AM; Spector TD
Lancet Infect Dis; 2022 Jul; 22(7):1002-1010. PubMed ID: 35405090
[TBL] [Abstract][Full Text] [Related]
46. Clinical significance of hepatosplenic thrombosis in vaccine-induced immune thrombotic thrombocytopenia after ChAdOx1 nCoV-19 vaccination.
Hwang J; Han YJ; Yon DK; Lee SW; Kim BK; Lee SB; Lee MH; Park SH; Koyanagi A; Jacob L; Tizaoui K; Kim SU; Shin JI; Smith L
Int J Infect Dis; 2022 Mar; 116():114-121. PubMed ID: 34958931
[TBL] [Abstract][Full Text] [Related]
47. Clinical cardiovascular emergencies and the cellular basis of COVID-19 vaccination: from dream to reality?
Li YE; Wang S; Reiter RJ; Ren J
Int J Infect Dis; 2022 Nov; 124():1-10. PubMed ID: 36075372
[TBL] [Abstract][Full Text] [Related]
48. The aetiopathogenesis of vaccine-induced immune thrombotic thrombocytopenia.
Toh CH; Wang G; Parker AL
Clin Med (Lond); 2022 Mar; 22(2):140-144. PubMed ID: 35273026
[TBL] [Abstract][Full Text] [Related]
49. SARS-CoV-2 Vaccine-Induced Immune Thrombotic Thrombocytopenia.
Cines DB; Bussel JB
N Engl J Med; 2021 Jun; 384(23):2254-2256. PubMed ID: 33861524
[No Abstract] [Full Text] [Related]
50. Vaccine-induced immune thrombotic thrombocytopenia: a possible pathogenic role of ChAdOx1 nCoV-19 vaccine-encoded soluble SARS-CoV-2 spike protein.
De Michele M; Piscopo P; Crestini A; Rivabene R; D'Amati G; Leopizzi M; Stefanini L; Pulcinelli F; Chistolini A; Iacobucci M; Schiavo OG; Berto I; Nicolini E; Petraglia L; Di Mascio MT; Toni D
Haematologica; 2022 Jul; 107(7):1687-1692. PubMed ID: 35172564
[No Abstract] [Full Text] [Related]
51. Anaphylaxis to SARS-CoV-2 Vaccines in the Setting of a Nationwide Passive Epidemiological Surveillance Program.
Toledo-Salinas C; Scheffler-Mendoza SC; Castano-Jaramillo LM; Ortega-Martell JA; Del Rio-Navarro BE; Santibáñez-Copado AM; Díaz-Ortega JL; Baptista-Rosas R; Sánchez-Novoa P; García-Grimshaw M; Valdés-Ferrer SI; Reyes-Terán G; Mendoza-Hernández DA
J Clin Immunol; 2022 Nov; 42(8):1593-1599. PubMed ID: 35976470
[TBL] [Abstract][Full Text] [Related]
52. A case of acute demyelinating polyradiculoneuropathy with bilateral facial palsy after ChAdOx1 nCoV-19 vaccine.
Nasuelli NA; De Marchi F; Cecchin M; De Paoli I; Onorato S; Pettinaroli R; Savoini G; Godi L
Neurol Sci; 2021 Nov; 42(11):4747-4749. PubMed ID: 34272622
[TBL] [Abstract][Full Text] [Related]
53. Humoral response to SARS-CoV-2 adenovirus vector vaccination (ChAdOx1 nCoV-19 [AZD1222]) in heart transplant recipients aged 18 to 70 years of age.
Tanner R; Starr N; Chan G; Dempsey E; Heffernan E; Newman E; O'Neill J; Hannan MM; Lynch B; Joyce E
J Heart Lung Transplant; 2022 Apr; 41(4):492-500. PubMed ID: 35090809
[TBL] [Abstract][Full Text] [Related]
54. [Immune thrombocytopenia after BNT162b2 mRNA COVID-19 vaccination].
Sato K; Anayama M; Sumi M; Kobayashi H
Rinsho Ketsueki; 2021; 62(12):1688-1693. PubMed ID: 35022338
[TBL] [Abstract][Full Text] [Related]
55. Recommendations on the Management of Patients with Immune Thrombocytopenia (ITP) in the Context of SARS-CoV-2 Infection and Vaccination: Consensus Guidelines from a Spanish ITP Expert Group.
González-López TJ; Bárez A; Bernardo-Gutiérrez A; Bernat S; Canaro-Hirnyk M; Entrena-Ureña L; Fernández-Fuertes F; Guinea de Castro JM; Jiménez-Bárcenas R; Pascual-Izquierdo C; Sánchez-González B; Jarque I
Infect Dis Ther; 2023 Feb; 12(2):303-315. PubMed ID: 36520323
[TBL] [Abstract][Full Text] [Related]
56. Possible Risk of Thrombotic Events following Oxford-AstraZeneca COVID-19 Vaccination in Women Receiving Estrogen.
Soltani Hekmat A; Javanmardi K
Biomed Res Int; 2021; 2021():7702863. PubMed ID: 34734086
[TBL] [Abstract][Full Text] [Related]
57. Clinical characteristics in immune thrombocytopenia patients after COVID-19 vaccination.
Feng Y; Quan Y; Cassady K; Zou Z; Gao Y; Zhang X
Hum Vaccin Immunother; 2022 Nov; 18(6):2119043. PubMed ID: 36069667
[TBL] [Abstract][Full Text] [Related]
58. Recurrent Anterior Non-necrotizing Scleritis as an Adverse Event of ChAdOx1 nCoV-19 (Vaxzevria) Vaccine.
Hernanz I; Arconada C; López Corral A; Sánchez-Pernaute O; Carreño E
Ocul Immunol Inflamm; 2022 Jul; 30(5):1247-1249. PubMed ID: 35394853
[TBL] [Abstract][Full Text] [Related]
59. Manufacturing a chimpanzee adenovirus-vectored SARS-CoV-2 vaccine to meet global needs.
Joe CCD; Jiang J; Linke T; Li Y; Fedosyuk S; Gupta G; Berg A; Segireddy RR; Mainwaring D; Joshi A; Cashen P; Rees B; Chopra N; Nestola P; Humphreys J; Davies S; Smith N; Bruce S; Verbart D; Bormans D; Knevelman C; Woodyer M; Davies L; Cooper L; Kapanidou M; Bleckwenn N; Pappas D; Lambe T; Smith DC; Green CM; Venkat R; Ritchie AJ; Gilbert SC; Turner R; Douglas AD
Biotechnol Bioeng; 2022 Jan; 119(1):48-58. PubMed ID: 34585736
[TBL] [Abstract][Full Text] [Related]
60. Vocal fold paralysis following first dose of Oxford-AstraZeneca coronavirus disease 2019 vaccine.
Jama GM; Amin M; Hassaan A; Kaddour H
J Laryngol Otol; 2022 May; 136(5):466-468. PubMed ID: 35510490
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
